Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC). (Q38821208)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 November 2015

Language	Label	Description	Also known as
English	Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).	scientific article published on 7 November 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC). (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

invasive ductal carcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal adenocarcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Zequn Li

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Pengfei Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Chao Gao

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Cheng Peng

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Song Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Huijie Gao

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Ben Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jiayong Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jun Niu

9

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Weibo Niu

10

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

7 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

5117-5131

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Advanced pancreatic carcinoma: current treatment and future challenges

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Pancreatic cancer: diagnosis and treatments

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Defining the role of integrin alphavbeta6 in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Integrin adhesion receptors in tumor metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Alphavbeta6 integrin in wound healing and cancer of the oral cavity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

β6 integrin induces the expression of metalloproteinase-3 and metalloproteinase-9 in colon cancer cells via ERK-ETS1 pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

mTOR signaling pathway is a target for the treatment of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

alphavbeta5/beta6 integrin suppression leads to a stimulation of alpha2beta1 dependent cell migration resistant to PI3K/Akt inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4353-7

21 January 2018

Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26547582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The integrin alphavbeta6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26547582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26547582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26547582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct integrin alphavbeta6-ERK binding: implications for tumour growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/26547582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-015-4353-7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38821208&oldid=2202114711"